Never Run Out Of Buyers To Sell To.

ElevateBio Life Edit is focused on advancing next-generation gene editing technologies and therapeutics.We have built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs), base editors, and reverse transcriptase (RT) editors, opening a new frontier of gene editing. With multiple editing modalities and protein engineering expertise, our technology can modify gene targets both in vivo and ex vivo to potentially address the most challenging genetic diseases.
Annual Revenue$50M to $100M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.